MedTrace Logo

Low Pulse Amplitude Seizure Therapy (LAP-ST Study)

NCT02928159 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2016-10-10

No results posted yet for this study

Summary

This study assesses the feasibility of a full course of Low Pulse Amplitude-Seizure Therapy (LAP-ST) (primary outcome).

Conditions

  • Mood Disorders
  • Schizophrenia Spectrum and Other Psychotic Disorders

Interventions

DEVICE

Mecta spectrum 5000Q device

LAP-ST and Right Unilateral (RUL) electrode placement.

Sponsors & Collaborators

  • Behman Hospital

    lead OTHER

Principal Investigators

  • Nagy A. Youssef · Medical College of Georgia, Augusta University

  • Emad Sidhom · Behman Hospital

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2015-06-30
Completion
2015-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02928159 on ClinicalTrials.gov